全部| 求助中| 待确认 按时间排序|按积分排序

Adjunctive PCSK9 Inhibitor Evolocumab in the Prevention of Early Neurological Deterioration in Non-cardiogenic Acute Ischemic Stroke: A Multicenter, Prospective, Randomized, Open-Label, Clinical Trial

答案Answerball 1天前 10 已完结

Lerodalcibep and evolocumab for the treatment of homozygous familial hypercholesterolaemia with PCSK9 inhibition (LIBerate-HoFH): a phase 3, randomised, open-label, crossover, non-inferiority trial

答案Answerball 1天前 10 已完结

超分子技术在化妆品中的应用与展望.

用户rZPGn07oZTCk 1天前 10 求助中

A new index of abdominal adiposity as an indicator of risk for cardiovascular disease. A cross-population study

用户es0qWE3arrJk 1天前 10 求助中

In vivo inhibition of Helicobacter pylori through probiotics and gastrointestinal commensals: a critical review

用户1oor83NH7Asw 1天前 10 待确认

A Phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysis

用户TBS_MGy5GuJQ 2天前 10 待确认

An anti–glypican 3/CD3 bispecific T cell–redirecting antibody for treatment of solid tumors

用户RcsoTKlzyIwM 2天前 20 待确认

CD3 bispecific antibody–induced cytokine release is dispensable for cytotoxic T cell activity

用户RcsoTKlzyIwM 2天前 20 待确认

Inavolisib plus letrozole or fulvestrant in PIK3CA-mutated, hormone receptor-positive, HER2-negative advanced or metastatic breast cancer (GO39374): An open-label, multicentre, dose-escalation and dose-expansion phase 1/1b study

用户slK1Kxicm8Dw 2天前 10 待确认

Decade trends in risk factors, treatments, and prognosis of minor ischemic stroke and tia in china

用户5bhSNFD5fuQo 2天前 10 已完结
首页 上页 6 7 8 9 10 11 12 下页

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com